Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Topical Levofloxacin 1.5% vs Moxifloxacin 0.5% in Vitrectomy Patients
NCT04214821Phase 2Unknown
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Sep 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levofloxacin in endophthalmitis (8 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Maximum Concentration at 6 hours, Area Under the Curve and 1 more. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT04214821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214821.